anonymous
Guest
anonymous
Guest
Yes, 5000 shares of stock options.Any stock??
Yes, 5000 shares of stock options.Any stock??
On the low endYes, 5000 shares of stock options.
Not bad for a start up biotech! Hopefully they offer RSU's of Stock at sign on, competitive 401K, and decent benefits. If bonus at plan is ~50k, I'm all in.
Well if u want to sell Vitamin D then go for it but if you want to sell a breakthrough treatment for metabolic acidosis with mortality data then Tricida is the place to be.
$2000/month and no Medicare Part D with expectation of 75 Rx’s/month in the first Q of launch. Isn’t this the same CEO that fired the entire Rylepsa team after 1 Q?My nephrology buddies use baking soda, if this is priced crazy....its going to be tough! Max salary only 165k.
$2000/month and no Medicare Part D with expectation of 75 Rx’s/month in the first Q of launch. Isn’t this the same CEO that fired the entire Rylepsa team after 1 Q?
From the interview process. And shame on you if you didn’t ask about coverage and performance expectations. If you have been around you would understand that commercial coverage alone will not sustain this business. And you can always do your own research. It is out there.No Medicare part D? That could be a slight problem considering most patients will be Medicare age. This is good info, but how do I know you are legit with tho info? No offense but Cafepharma is filled with people that make stuff up. Where did you get your info With coverage and NRX requirements? If you are legit this will make me rethink for sure
Look at their investor page. Plain as day and right out in the open. Are you so ignorant that you do not know how a drug launch works? Of course there are pre-launch negotiations. Look it up. 85% of the targeted patient base is over 65 and retired. That would be Medicare Part D country. If you are a rep you deserve this upcoming shit storm.how can you know insurance coverage if the drug isn’t launched yet
Unless that shit can cure covid-19 it is dead for this year.Look at their investor page. Plain as day and right out in the open. Are you so ignorant that you do not know how a drug launch works? Of course there are pre-launch negotiations. Look it up. 85% of the targeted patient base is over 65 and retired. That would be Medicare Part D country. If you are a rep you deserve this upcoming shit storm.
Look at their investor page. Plain as day and right out in the open. Are you so ignorant that you do not know how a drug launch works? Of course there are pre-launch negotiations. Look it up. 85% of the targeted patient base is over 65 and retired. That would be Medicare Part D country. If you are a rep you deserve this upcoming shit storm.
Thanks for your kind remarks I hope you and your family get Covid!Look at their investor page. Plain as day and right out in the open. Are you so ignorant that you do not know how a drug launch works? Of course there are pre-launch negotiations. Look it up. 85% of the targeted patient base is over 65 and retired. That would be Medicare Part D country. If you are a rep you deserve this upcoming shit storm.
Oh how nice. With that attitude and your ignorance of the market I’m am sure you’ll be a success with the nephrologists who have just had to sign death certificates. Ex-Forest rep or a newly minted Allergan brown shirt?Thanks for your kind remarks I hope you and your family get Covid!
During the interview process in February, I asked and surveyed my top nephrologist prescribers to gather their thoughts about the product. Despite our strong relationship, they all told me that they would not prescribe, and even counseled me against taking the job unless I’m really, really desperate to leave my current one.The management team is smoking some of the good stuff. And for those of you who accepted their generous offer, good luck. The data is not strong enough to support this product. Nephrologists are not going to buy into this one as easily as management says.